Treatment of H. pylori infection: the reality.

Por Vakil, N.
Publicado em 1998

Blood, urine, stool, breath, money, and Helicobacter pylori

Por VAIRA, D, VAKIL, N
Publicado em 2001

Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease

Por Vakil, N, Niklasson, A, Denison, H, Rydén, A
Publicado no United European Gastroenterol J (2015)

Sleep disturbance due to heartburn and regurgitation is common in patients with functional dyspepsia

Por Vakil, N, Wernersson, B, Wissmar, J, Dent, J
Publicado no United European Gastroenterol J (2015)

Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs

Por Dent, J, Armstrong, D, Delaney, B, Moayyedi, P, Talley, N, Vakil, N
Publicado em 2004

Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies.

Por Dunn, B E, Vakil, N B, Schneider, B G, Miller, M M, Zitzer, J B, Peutz, T, Phadnis, S H
Publicado em 1997

Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects

Por Vaira, D, Vakil, N, Rugge, M, Gatta, L, Ricci, C, Menegatti, M, Leandro, G, Holton, J, Russo, V M, Miglioli, M
Publicado em 2003

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

Por Malfertheiner, P, Megraud, F, O'Morain, C, Bazzoli, F, El‐Omar, E, Graham, D, Hunt, R, Rokkas, T, Vakil, N, Kuipers, E J
Publicado em 2007

Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

Por Shaheen, N. J., Adler, J., Dedrie, S., Johnson, D., Malfertheiner, P., Miner, P., Meulemans, A., Poole, L., Tack, J., Thielemans, L., Troy, S., Vakil, N., Zerbib, F., Ruth, M.
Publicado no Aliment Pharmacol Ther (2015)